MDMohammed Gebre Dedefo

Mohammed Gebre Dedefo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammed Gebre Dedefo has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Consumers’ experiences and perspectives on reporting adverse drug reactions using digital tools: a qualitative study

    by Mohammed Gebre Dedefo, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, Renly Lim, Elizabeth Roughead, Lisa Kalisch Ellett

    Introduction: Spontaneous adverse drug reactions (ADRs) are underreported. Digital reporting systems are increasingly used to address this issue; however, limited knowledge exists about the barriers and facilitators influencing their use by consumers. Aim: To explore facilitators and barriers influencing consumers’ use of digital tools for ADR reporting, and to identify the factors, expectations and preferences that affect their engagement with these tools. Method: An exploratory qualitative descriptive study using semi-structured in-depth interviews was conducted among Australian adults who self-reported having experienced an ADR. Interviews were conducted face-to-face or via Zoom, audio-recorded, transcribed verbatim, and analysed inductively using reflexive thematic analysis. Themes were mapped onto domains of the Combined Technology Acceptance Model and Theory of Planned Behaviour (C-TAM-TPB) framework. Results: Fourteen participants were interviewed. Consumers expressed positive intentions to use online ADR reporting tools. Identified facilitators included user-friendly and accessible tools that are simple to complete, the use of images to aid comprehension, integration with existing patient health records, the ability to submit reports to both healthcare professionals and regulators, and a tool designed specifically for consumers using layperson language. Identified barriers included lack of awareness that consumers could report ADRs using online tools, the need for registration, complex medical terminology, compulsory fields, and the absence of feedback after submission. Conclusion: Consumers were willing to use online ADR reporting tools but were largely unaware of their existence. Enhancing usability through user-friendly design, and reporting forms specifically designed for consumers may increase engagement. Addressing barriers such as lack of awareness, registration requirements, medical jargon, and lack of feedback may improve usability and contribute to strengthening pharmacovigilance systems.

  • Open Access

    Awareness of the Black Triangle Scheme among healthcare professionals and consumers in Australia: A mixed‐methods study exploring reporting intentions and suggested improvements

    by Eyob Alemayehu Gebreyohannes, Sieta T. de Vries, Mohammed Gebre Dedefo, Oliver Frank, Myra Thiessen, Lisa Kalisch Ellett, Christopher Thornton, Renly Lim

    Aims: The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements. Methods: A mixed‐methods study was conducted (August–December 2024) consisting of an online questionnaire and follow‐up interviews with HCPs (doctors, pharmacists, nurses) and consumers in Australia. Descriptive and qualitative data analyses were conducted. Results: A total of 405 participants completed the questionnaire (138 HCPs, 267 consumers). Half of the HCPs (52%) and a tenth of the consumers (10%) were aware of the scheme. After viewing the symbol, 66.2% reported being likely or very likely to report an ADE linked to a medicine carrying it. Twenty‐one participated in the interviews (11 HCPs, 10 consumers). Interviewees suggested various strategies to improve awareness, including social media, television, posters and printed labels. Most noted that the Black Triangle symbol, in its current form and placement within medicine leaflets, is easy to miss. Once the scheme's purpose was explained, participants described it as “very important” and a “good initiative” to enhance medicine safety. Interview participants expressed mixed views on the scheme's impact on their future ADE reporting. Conclusion: Awareness of the scheme was notably lower among consumers than HCPs. Once informed, most participants viewed the scheme favourably and indicated a greater likelihood of reporting. However, issues related to the visibility and meaning of the Black Triangle symbol were raised.

  • Open Access

    Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries

    by Mohammed Gebre Dedefo, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, Renly Lim, Elizabeth Roughead, Lisa Kalisch Ellett

    This study assessed whether the completeness of spontaneously reported adverse drug reaction (ADR) reports differs between consumers and healthcare professionals when submitted directly to regulators, and how this compares to reports from pharmaceutical companies. ADR reports (2014–2023) were obtained from public databases in Canada and the United Kingdom (UK), focusing on the medicine classes sodium‐glucose cotransporter 2 inhibitors, glucagon‐like peptide 1 receptor agonists, and dipeptidyl peptidase‐4 inhibitors. ADR report completeness was assessed using vigiGrade tool variables. Descriptive statistics and chi‐square tests were used for analysis. A total of 17 897 reports were analyzed—13 613 from the UK Yellow Card Scheme and 4284 from Canada. Most Canadian reports were submitted by pharmaceutical companies (55%), while in the UK, healthcare professionals submitted the majority (69%). Few reports were submitted directly by consumers in either Canada (4%) or the UK (7%). In Canada, the average completeness was 82% for consumer and healthcare professional reports and 57% for pharmaceutical companies. In the UK, completeness was 80% (consumers), 82% (healthcare professionals), and 69% (pharmaceutical companies). Canadian pharmaceutical company reports were significantly less complete for age, sex, outcome, dose, indication, and route of administration (all p < 0.001). In the UK, they were less complete for age, sex, and route of administration (all p < 0.001). In conclusion, reports submitted directly to regulators by consumers and healthcare professionals were more complete than those from pharmaceutical companies. The low consumer reporting rate, yet high completeness rate, highlights the need to encourage direct reporting to regulators to improve medicine safety monitoring.


  • Open Access

    Completeness of spontaneously reported adverse drug reactions in 4 databases

    by Mohammed Gebre Dedefo, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, Renly Lim, Elizabeth Roughead, Lisa Kalisch Ellett

    Aims: To assess the completeness of information provided in adverse drug reaction (ADR) reports in 4 spontaneous report databases. Methods: The study was conducted using freely accessible ADR reports from the Canada Vigilance Adverse Reaction Online Database, the US Food and Drug Administration Adverse Event Reporting System (FAERS) database, the UK Yellow Card Scheme and the Danish Medicines Agency ADR Database, covering the period 2014–2023. The variables used to evaluate the completeness of ADR reports were selected based on the vigiGrade completeness tool. Descriptive statistics were used to report the completeness of information in each ADR report, while chi‐square tests were used to analyse differences in completeness by seriousness of report. Results: In total, 290 079 individual case safety reports were analysed: 4289 from the Canadian database; 269 763 from the FAERS database; 13 624 from the UK Yellow Card Scheme; and 2403 from the Danish database. The most frequently completed information was the primary reporter, with nearly 100% completeness. The most frequently omitted information was the route of administration, with completion scores of 44% in the UK Yellow Card Scheme, 55% in the Danish database and 58% in the Canadian database. In FAERS, the event date was the most frequently omitted information with a completeness rate of 50%. Conclusion: The completeness of information varied across different variables, with information frequently omitted for route of administration and event date. Enhancing awareness about providing complete information during ADR reporting is essential for collecting complete data and allowing signal detection.


  • Open Access

    Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study

    by Mohammed Gebre Dedefo, Renly Lim, Gizat M. Kassie, Eyob Alemayehu Gebreyohannes, Nava Nikpay Salekdeh, Elizabeth Roughead, Lisa Kalisch Ellett

    Background: The application of digital technologies has shown benefits in enhancing pharmacovigilance activities but consumers views on the use of these tools for this purpose are not well described. Aim: To explore consumers’ views on using digital tools to report adverse drug reactions (ADRs) and identify key features that consumers want in digital tools for ADR reporting. Method: An online survey was conducted among adults who had taken medicine in the previous six-months in Australia. The development of questions was guided by the Combined Technology Acceptance Model and Theory of Planned Behaviour (C-TAM-TPB) framework. Responses to closed-ended questions were analysed using descriptive statistics and chi-square/Fisher’s exact test, while free-text responses were analysed using qualitative content analysis. Results: A total of 494 responses were included in the analysis. Eighty-seven percent of respondents preferred using digital tools for reporting ADRs. Consumers indicated a free-text space for describing ADRs (90%) as important or very important features of digital tools for ADR reporting, followed by acknowledgement of their report submission (87%) and receiving summary of previously reported ADRs (87%). Women (p < 0.001), advanced smartphone users (p < 0.001), and previous digital healthcare tool users (p = 0.017) showed higher intention to use digital tools. Consumers emphasized the importance of ease-of-use, accessibility, receiving medicine safety information, feedback, and advice for reporting ADRs via digital tools. Conclusion: Consumers prefer using digital tools for reporting ADRs and place high value on features such as a free-text space for describing ADRs, acknowledgement of report submissions, and access to summaries of previously submitted reports.


  • Open Access

    Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey

    by Mohammed Gebre Dedefo, Renly Lim, Gizat M. Kassie, Elizabeth Roughead, Lisa Kalisch Ellett

    This study aimed to investigate the current knowledge and experiences of consumers in Australia on adverse drug reaction (ADR) reporting and their reasons for reporting or not reporting ADRs, with a focus on the use of digital tools for ADR reporting. Methods: A cross-sectional online survey was conducted among adults who had taken medicine in Australia. A structured questionnaire with multiple choice or Likert scale responses with an option for participants to provide free-text responses and pretested for face validity was used. Consumer characteristics, knowledge, and ADR reporting practices were analyzed using descriptive statistics and the chi-square test or Fisher’s exact test. Results: A total of 544 survey responses were included in the analysis. The majority of respondents were women (68%), and 22% were aged between 65 and 74 years. Fifty-eight percent (n = 317) of respondents knew that they could report ADRs to either the Therapeutic Goods Administration (TGA), state or territory government health department, or healthcare professionals. Three-quarters (n = 405) of respondents stated that they had experienced an ADR; of these, 36% reported an ADR to either the TGA, state or territory government health department, or healthcare professionals. Among those who reported ADRs, 58% were unaware that they could use digital tools to report ADRs. The main reason for not reporting was that they did not think the ADR was serious enough to report (39%). Conclusion: Over half of consumers knew that they could report ADR; however, improved consumer awareness about using digital tools for ADR reporting and increased ADR reporting is needed.


  • Open Access

    Medication Errors Among Hospitalized Adults in Medical Wards of Nekemte Specialized Hospital, West Ethiopia: A Prospective Observational Study

    by Mohammed Gebre, Nigatu Addisu, Ayantu Getahun, Jenber Workye, Busha Gamachu, Ginenus Fekadu, Tesfa Tekle, Bizuneh Wakuma, Getahun Fetensa, Balisa Mosisa, et al.

    Purpose: A high prevalence of medication errors in older adults are due to a combination of different factors such as polypharmacy, polymorbidity, enrolment in several disease-management programs, and fragmentation of care that causes medication errors in all age groups. This study aims to assess the incidence and determinants of medication errors among hospitalized adults in medical wards of Nekemte Specialized Hospital (NSH), West Ethiopia. Patients and Methods: A prospective observational study design was conducted at Nekemte Specialized Hospital among hospitalized adults from October 30, 2018 to January 30, 2019. Data were collected by using checklist-guided observation and review of medication order sheets, medication administration records, and patient charts. To identify the independent predictors of medication errors, logistic regression analysis was used. Statistical significance was considered at a p-value < 0.05. Results: A total of 351 patients were included in the present study. The mean age of the patients was 40.67+15.78 years. A total of 813 medication errors were recorded. The most common stage for medication errors was physician ordering 263 (32.4%). In the multivariable analysis, age ≥ 65 years (AOR: 2.54, 95%CI: 1.12– 5.75, p=0.025), hospital stay ≥ 7 days (AOR: 2.16, 95%CI: 1.17– 3.98, p=0.014), number of medication taken (AOR: 1.75, 95%CI: 1.13– 2.73, p=0.013) and presence of comorbidity (AOR: 1.57, 95%CI: 1.01– 2.46, p=0.049) had shown statistical significance in predicting medication errors. Conclusion: Medication errors are common at Nekemte Specialized Hospital with an incidence of 48.3 per 100 orders, 231.6 per 100 admissions, and 433.4 per 1000 patient days. In particular, adults with older age, increased hospital stay, a greater number of medications, and presence of comorbidities were at greater risk for medication errors.


  • Open Access

    Knowledge of obstetric danger signs and associated factors among pregnant women in Wolaita Sodo town, South Ethiopia: A community-based cross-sectional study

    by Alemu Bolanko, Hussen Namo, Kirubel Minsamo, Nigatu Addisu, Mohammed Gebre

    Introduction: Obstetric complications continue to be the major causes of maternal mortality in low- and middle-income countries. Knowledge of women toward obstetric danger signs is an important part of improving maternal and fetal outcomes. However, the reported level of knowledge on obstetric danger signs is low and inconsistent. Methods: Community-based cross-sectional study design was used. Data were collected from randomly selected 740 pregnant women. A pregnant woman said to have good knowledge of obstetric danger signs if she spontaneously mentioned at least two of the danger signs during each of the three periods (pregnancy, labor/childbirth, and postpartum) and otherwise said to have poor knowledge of obstetric danger signs. Adjusted odds ratio at 95% confidence interval and a value of p < 0.05 were used to identify the predictors. Results: A total of 740 pregnant women participated in the study with the response rate of 97.5%. One hundred twenty-four (16.8%) of the respondents were knowledgeable about obstetric danger signs. According to our study, age range of 20–24 years (adjusted odds ratio = 6, confidence interval: 2.67–17.44) and 25–29 years old (adjusted odds ratio = 2.4, confidence interval: 1.14–5.10); being housewife (adjusted odds ratio = 0.5, confidence interval: 0.28–0.87); monthly income of ⩽1000ETB (adjusted odds ratio = 0.24, confidence interval: 0.12–0.46) and 1001-2500ETB (adjusted odds ratio = 0.24, confidence interval: 0.12–0.47); and primigravida (adjusted odds ratio = 0.09, confidence interval: 0.04–0.18) and primipara (adjusted odds ratio = 0.15, confidence interval: 0.07–0.30) were factors significantly associated with knowledge of obstetric danger signs. Conclusion: Knowledge of obstetric danger signs among pregnant women was low. Maternal age, average monthly income, maternal occupation, parity, and gravidity were factors significantly associated with the knowledge of obstetric danger signs.


  • Open Access

    Adherence to Anti-Tuberculosis Treatment Among Pediatric Patients at Nekemte Specialized Hospital, Western Ethiopia

    by Ginenus Fekadu, Firomsa Bekele, Kumera Bekele, Tsiyon Girma, Getu Mosisa, Mohammed Gebre, Tamirat Alemu, Tesfa Tekle, Busha Gamachu, Amenu Diriba

    Background: Non-adherence to tuberculosis treatment is the most challenging and hindering factor for successful tuberculosis therapy. The long duration of tuberculosis treatment and the undesirable effects of anti-tuberculosis drugs result in non-adherence to treatment among pediatric patients. Hence, this study was aimed to evaluate pediatrics adherence status among tuberculosis pediatric patients on anti-tuberculosis treatment at Nekemte Specialized Hospital. Methods: A health facility-based cross-sectional study design was used to recruit pediatric TB patients who were receiving their treatment between February 15 and March 15, 2019. Adherence to tuberculosis therapy was evaluated using data obtained from face-to-face interviews of their respective caregivers. The collected data were entered into EPI-manager 4.0.2 software and analyzed using SPSS version 24. Logistic regression was used to analyze the variables and variables with p-value < 0.05 had a statistically significant association with the adherence to anti TB treatment. Results: Among 202 participants involved in the study, 120 (59.4%) of them were males and 119 (58.9%) were in the age category of 11– 15 years. A total of 166 (82.2%) of the patients had extra-pulmonary tuberculosis and 174 (86.1%) of them were in the intensive phase. Of the pediatric tuberculosis patients, 48 (73.3%) of them have adhered to the treatment regimen. Female gender [AOR: 3.3, 95% CI: 1.52– 7.2], younger age (0– 5 years) [AOR: 5.96 95% CI: 1.81– 19.6], living in urban area [AOR: 3.73, 95% CI: 1.67– 8.36], and patients who did not experience side effect [AOR: 2.87, 95% CI: 1.41– 5.81] were predictors of good adherence to tuberculosis treatment up on multivariable logistic regression analysis. Conclusion: The level of adherence observed in our study area was low. Age, sex, residence, and side effect experience showed an association with tuberculosis treatment adherence. Therefore, health care providers should educate all patients with tuberculosis before the initiation of anti-tuberculosis treatment.


  • Open Access

    Magnitude and Determinants of Uncontrolled Blood Pressure Among Adult Hypertensive Patients on Follow-Up at Nekemte Referral Hospital, Western Ethiopia

    by Ginenus Fekadu, Abdi Adamu, Mohammed Gebre, Busha Gamachu, Firomsa Bekele, Muktar Abadiga, Getu Mosisa, Adugna Oluma

    Background: Hypertension is the leading cause of morbidity and mortality among non-communicable diseases. The rate of blood pressure (BP) control among hypertensive patients is poor and the reasons for poor control of BP remain poorly understood globally. Therefore, this study aimed to assess the magnitude and determinants of uncontrolled blood pressure among adult hypertensive patients on follow-up at Nekemte referral hospital (NRH). Methods: A hospital-based cross-sectional study was conducted from February to April 2018 at NRH. BP control status was determined by the average consecutive BP recordings across the 3 months. The data was entered and analyzed using SPSS version 20.0 and p-value < 0.05 was considered statistically significant. Results: Out of 297 study participants included, the majority were females, 181 (60.9%), and the mean age of the patients was 59.4 ± 10.4 years. About half, 137 (46.12%), of the patients had at least one comorbidity and the most common class of anti-hypertensive medication was angiotensin-converting enzyme inhibitors (88.2%). The mean of systolic blood pressure was 132.41± 15.61mmHg, while the mean of diastolic blood pressure was 84.37± 9.32 mmHg. The proportion of participants with optimally controlled BP was 63.6% and 36% were adherent to their medications. Male sex (Adjusted Odd Ratio [AOR]: 1.89, 95% CI: 1.09– 4.84), illiteracy (AOR= 1.56, 95% CI: 1.22– 6.78), duration of hypertension diagnosis > 10 years (AOR= 2.01, 95% CI: 1.04– 16.11), non-adherence (AOR= 3.14, 95% CI: 1.35– 10.76) and lack of physical exercise (AOR= 2.8, 95% CI: 1.16– 6.74) were positively associated with uncontrolled BP status. Whereas age older than 55 years (AOR= 0.38, 95% CI: 0.11– 0.92) was negatively associated with uncontrolled BP. Conclusion: BP control was relatively achieved in about two-third of pharmacologically treated patients. We recommend better health education and care of patients to improve the rate of BP control status.